HeartWare revenue grows, losses widen in Q3

Fri, 11/09/2012 - 1:59pm
Mass Device

HeartWare shares remain flat after the company posts Q3 increases in sales but widening losses.

HeartWare logo

HeartWare International (NSDQ:HTWR) saw strong growth in its sales in the 3rd quarter, but increased its losses by 79% compared with the same period last year.

The Framingham-based cardiac device maker posted $25 million in net losses, or $1.75 per share on sales of $22.9 million for the 3 months ended Sept. 30. That compared with a net loss of $14 million, or $1 per share on sales of $21.3 million during the same period last year.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.